These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9322542)

  • 1. Colorectal cancer screening: clinical guidelines and rationale.
    St John DJ; Macrae FA; Young GP
    Gastroenterology; 1997 Oct; 113(4):1422; author reply 1424. PubMed ID: 9322542
    [No Abstract]   [Full Text] [Related]  

  • 2. Colorectal cancer screening: clinical guidelines and rationale.
    Ransohoff DF; Lang CA; Young GP
    Gastroenterology; 1997 Oct; 113(4):1423-4. PubMed ID: 9322544
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of three stool tests for colorectal cancer screening.
    Greenwald B
    Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
    Skitek M
    Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
    [No Abstract]   [Full Text] [Related]  

  • 5. Colorectal cancer screening.
    McLoughlin RM; O'Morain CA
    World J Gastroenterol; 2006 Nov; 12(42):6747-50. PubMed ID: 17106920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacing guaiac-based tests with immunochemical tests in colorectal cancer screening.
    Schlackman N
    Am J Med; 2003 Aug; 115(2):154; author reply 154-5. PubMed ID: 12893403
    [No Abstract]   [Full Text] [Related]  

  • 7. Faecal occult blood testing for colorectal cancer: luxury or necessity?
    Agrez M; Evans D; Duggan J
    Aust N Z J Surg; 1990 Jun; 60(6):451-4. PubMed ID: 2346441
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for colorectal neoplasias with fecal occult blood tests: false-positive impact of non-dietary restriction.
    Roslani AC; Abdullah T; Arumugam K
    Asian Pac J Cancer Prev; 2012; 13(1):237-41. PubMed ID: 22502676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
    Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
    Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
    Blom J; Törnberg S
    J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical versus guaiac fecal occult blood tests.
    Technol Eval Cent Assess Program Exec Summ; 2004 Jul; 19(5):1-3. PubMed ID: 15473055
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the sensitivity of fecal occult blood test screening for colorectal cancer.
    Lang CA; Ransohoff DF
    J Natl Cancer Inst; 1997 Oct; 89(19):1392-3. PubMed ID: 9326904
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled prospective study of faecal occult blood screening for colorectal cancer in Bury, black pudding capital of the world.
    Fludger S; Turner AM; Harvey RF; Haslam N
    BMJ; 2002 Dec; 325(7378):1444-5. PubMed ID: 12493657
    [No Abstract]   [Full Text] [Related]  

  • 15. Colorectal cancer screening: A guide to the guidelines.
    Rex DK
    Can J Gastroenterol; 1999 Jun; 13(5):397-402. PubMed ID: 10377470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
    Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which colorectal cancer screening test is best?
    Mandel JS
    J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
    [No Abstract]   [Full Text] [Related]  

  • 18. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network.
    Benson VS; Atkin WS; Green J; Nadel MR; Patnick J; Smith RA; Villain P;
    Int J Cancer; 2012 Jun; 130(12):2961-73. PubMed ID: 21792895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast track referrals for colorectal cancer: the impact of the faecal occult blood test screening programme.
    Ward N; Wright J; Marsh S; Norton J
    Colorectal Dis; 2007 Mar; 9(3):258-61. PubMed ID: 17298625
    [No Abstract]   [Full Text] [Related]  

  • 20. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests.
    Ko CW; Dominitz JA; Nguyen TD
    Am J Med; 2003 Aug; 115(2):111-4. PubMed ID: 12893396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.